ProCE Banner Activity

Practical Considerations for Administration of Asparaginase-Based Therapy to Patients With ALL

Slideset Download
Download this slideset from a live CCO symposium for an expert overview of considerations regarding the use of asparaginase in the treatment of ALL, including discussion of available formulations and optimal management of hypersensitivity reactions.

Released: December 15, 2021

Expiration: December 14, 2022

No longer available for credit.
Begin Activity

Share

Faculty

Stephen P. Hunger

Stephen P. Hunger, MD

Chief, Division of Pediatric Oncology
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Jazz Pharmaceuticals

Servier Oncology Global Medical and Patient Affairs

Servier Pharmaceuticals

Faculty Disclosure

Primary Author

Stephen P. Hunger, MD

Chief, Division of Pediatric Oncology
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania